Connors Investor Services Inc. Sells 1,378 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Connors Investor Services Inc. decreased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.8% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 34,651 shares of the company’s stock after selling 1,378 shares during the quarter. Connors Investor Services Inc. owned approximately 0.07% of Prestige Consumer Healthcare worth $2,386,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Opal Wealth Advisors LLC purchased a new position in Prestige Consumer Healthcare during the second quarter valued at $26,000. Principal Securities Inc. purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter valued at about $29,000. Quest Partners LLC increased its holdings in shares of Prestige Consumer Healthcare by 2,826.7% in the second quarter. Quest Partners LLC now owns 439 shares of the company’s stock worth $30,000 after purchasing an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in Prestige Consumer Healthcare by 80.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after acquiring an additional 208 shares during the last quarter. Finally, Gladius Capital Management LP purchased a new stake in Prestige Consumer Healthcare during the second quarter valued at $35,000. Institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

Prestige Consumer Healthcare stock opened at $73.68 on Tuesday. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The firm has a market capitalization of $3.65 billion, a P/E ratio of 17.67, a price-to-earnings-growth ratio of 2.06 and a beta of 0.48. Prestige Consumer Healthcare Inc. has a 1-year low of $56.34 and a 1-year high of $75.80. The company’s 50-day moving average is $70.88 and its 200 day moving average is $69.58.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.04. The firm had revenue of $267.10 million for the quarter, compared to the consensus estimate of $260.54 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The company’s revenue for the quarter was down 4.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.06 earnings per share. Research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on PBH shares. Canaccord Genuity Group restated a “buy” rating and issued a $80.00 target price on shares of Prestige Consumer Healthcare in a report on Tuesday, May 21st. DA Davidson raised their price objective on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Finally, StockNews.com downgraded Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $98.75.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.